Work

AMG 386, a selective angiopoietin 1/2-neutralizing peptibody, in combination with chemotherapy in adult patients with advanced solid tumors

Year: 2007

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2007.25.18_suppl.14033

Authors: A. C. Mita, D. Wang, C. H. Takimoto, E. Malseed, L. Nguyen, E. Rasmussen, C. Storgard, P. LoRusso

Institutions: Amgen (United States), The Barbara Ann Karmanos Cancer Institute

Language: English

Topic: Angiogenesis and VEGF in Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2280309969

Cites:

Cited by: 10

Related to: 10